Glenmark Pharmaceuticals Limited
GLENMARK
Quarterly results
Revenue and net profit
₹ crore
Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.
- Income
- ₹ crore
Jun 20262,435
Quarter ₹ crore YoY Jun 2024 2,330 +8.6% Sept 2024 2,636 +18.0% Dec 2024 2,251 +64.9% Mar 2025 2,009 -6.5% Jun 2025 2,395 +2.8% Sept 2025 1,539 -41.6% Dec 2025 2,360 +4.8% Mar 2026 2,147 +6.8% Jun 2026 2,435 +1.7% - ₹ crore
Jun 2026115
Quarter ₹ crore Jun 2024 56 Sept 2024 83 Dec 2024 129 Mar 2025 88 Jun 2025 69 Sept 2025 286 Dec 2025 109 Mar 2026 308 Jun 2026 115 - ₹ crore
Jun 20262,550
Quarter ₹ crore Jun 2024 2,385 Sept 2024 2,719 Dec 2024 2,380 Mar 2025 2,098 Jun 2025 2,464 Sept 2025 1,824 Dec 2025 2,469 Mar 2026 2,454 Jun 2026 2,550 - Cost structure
- ₹ crore
Jun 2026454
Quarter ₹ crore Jun 2024 384 Sept 2024 408 Dec 2024 428 Mar 2025 383 Jun 2025 408 Sept 2025 454 Dec 2025 467 Mar 2026 461 Jun 2026 454 - ₹ crore
Jun 20261,907
Quarter ₹ crore Jun 2024 1,767 Sept 2024 1,924 Dec 2024 1,821 Mar 2025 1,738 Jun 2025 1,740 Sept 2025 1,799 Dec 2025 1,945 Mar 2026 2,193 Jun 2026 1,907 - Exceptional items and tax
- ₹ crore
Jun 2026866
Quarter ₹ crore Jun 2024 618 Sept 2024 795 Dec 2024 559 Mar 2025 181 Jun 2025 401 Sept 2025 -906 Dec 2025 347 Mar 2026 -107 Jun 2026 866 - ₹ crore
Jun 2026130
Quarter ₹ crore Jun 2024 165 Sept 2024 200 Dec 2024 146 Mar 2025 33 Jun 2025 71 Sept 2025 -167 Dec 2025 64 Mar 2026 -33 Jun 2026 130 - Profit
- ₹ crore
Jun 2026736
Quarter ₹ crore YoY Jun 2024 454 +67.0% Sept 2024 595 +96.8% Dec 2024 414 +2127.6%* Mar 2025 148 -96.8% Jun 2025 330 -27.2% Sept 2025 -739 -224.2% Dec 2025 282 -31.8% Mar 2026 -74 -150.0% Jun 2026 736 +122.8% - Per share
- ₹ per share
Jun 202626.07
Quarter ₹ per share Jun 2024 16.08 Sept 2024 21.09 Dec 2024 14.66 Mar 2025 5.24 Jun 2025 11.70 Sept 2025 -26.19 Dec 2025 10.00 Mar 2026 -2.62 Jun 2026 26.07
| ₹ crore | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||
| 2,330 | 2,636 | 2,251 | 2,009 | 2,395 | 1,539 | 2,360 | 2,147 | 2,435 | |
| Revenue YoY | +8.6% | +18.0% | +64.9% | -6.5% | +2.8% | -41.6% | +4.8% | +6.8% | +1.7% |
| 56 | 83 | 129 | 88 | 69 | 286 | 109 | 308 | 115 | |
| 2,385 | 2,719 | 2,380 | 2,098 | 2,464 | 1,824 | 2,469 | 2,454 | 2,550 | |
| Cost structure | |||||||||
| 384 | 408 | 428 | 383 | 408 | 454 | 467 | 461 | 454 | |
| 1,767 | 1,924 | 1,821 | 1,738 | 1,740 | 1,799 | 1,945 | 2,193 | 1,907 | |
| Exceptional items and tax | |||||||||
| 618 | 795 | 559 | 181 | 401 | -906 | 347 | -107 | 866 | |
| 165 | 200 | 146 | 33 | 71 | -167 | 64 | -33 | 130 | |
| Profit | |||||||||
| 454 | 595 | 414 | 148 | 330 | -739 | 282 | -74 | 736 | |
| Net profit YoY | +67.0% | +96.8% | +2127.6%* | -96.8% | -27.2% | -224.2% | -31.8% | -150.0% | +122.8% |
| Per share | |||||||||
| 16.08 | 21.09 | 14.66 | 5.24 | 11.70 | -26.19 | 10.00 | -2.62 | 26.07 | |
Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.